Multiple Sclerosis
📧 Sign up to get email alerts when something new happens for Multiple Sclerosis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-03-10Clinical Trial Update: Tai Chi and Square-Stepping Exercises in Women With Multiple Sclerosis [NA]
A study assessing Tai Chi and square-stepping exercises in women with multiple sclerosis is currently recruiting.
-
CLINICAL_TRIALS trial_result · 2026-03-10Clinical Trial Update: DreaMS - Validation Study 1
Status update for the DreaMS Validation Study 1 showing the trial is currently active but not recruiting for Multiple Sclerosis.
-
CLINICAL_TRIALS research · 2026-03-09Clinical Trial Update: Implementation of an App-based Walking Aid Skills Training Program [NA]
A University of Calgary-sponsored clinical trial is evaluating an app-based walking aid skills training program and is currently recruiting …
-
EMA approval · 2026-03-06EMA Authorised: Tyruko (natalizumab) — Sandoz GmbH
The European Medicines Agency authorised Tyruko, a natalizumab biosimilar by Sandoz GmbH, for treatment of multiple sclerosis including the …
-
CLINICAL_TRIALS research · 2026-03-06Clinical Trial Update: Metaverse Applications in Clinical Neurorehabiliation: Device Feasibility [NA]
Clinical trial update on the feasibility of metaverse-based devices for neurological rehabilitation; the study is currently active but not r…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-03-06Clinical Trial Update: Study of Neuroinflammation in Multiple Sclerosis by PET-MRI Imaging Using the Radiotracer ([18F]-DPA-714) : a Multicentre Cohort Study (INFLANET) [NA]
This multicentre cohort study uses PET-MRI imaging with the radiotracer [18F]-DPA-714 to investigate neuroinflammation in multiple sclerosis…
-
CLINICAL_TRIALS research · 2026-03-06Clinical Trial Update: Wearable Focal Vibration Therapy on Upper Extremity Function of People With Multiple Sclerosis: A Pilot Study [NA]
Pilot study evaluating wearable focal vibration therapy to improve upper-extremity function in people with relapsing-remitting multiple scle…
-
CLINICAL_TRIALS research · 2026-03-06Clinical Trial Update: Exploring Cortical Remyelination in Children With Multiple Sclerosis [NA]
A clinical trial in Paris is recruiting children with multiple sclerosis to study cortical remyelination.
-
CLINICAL_TRIALS research · 2026-03-06Clinical Trial Update: Cognitive Performance, Sleep Disturbances and Fatigue in Multiple Sclerosis
A clinical trial led by Heinrich-Heine University in Dusseldorf is currently recruiting to study cognitive performance, sleep disturbances, …
-
CLINICAL_TRIALS research · 2026-03-05Clinical Trial Update: Spinal Cord Lesion Detection in Multiple Sclerosis Using Novel MRI Sequences [NA]
A clinical trial investigating spinal cord lesion detection in Multiple Sclerosis using novel MRI sequences is currently recruiting.
-
CLINICAL_TRIALS trial_result · 2026-03-05Clinical Trial Update: Impact of Adding Cognitive Behaviour Therapy to Supervised Pilates-based Core Stability Training in Patients With Multiple Sclerosis [NA]
A completed clinical trial evaluating whether adding cognitive behavioral therapy to supervised Pilates-based core stability training improv…
-
CLINICAL_TRIALS research · 2026-03-05Clinical Trial Update: Hesperidin RCT in MS [NA]
A clinical trial evaluating hesperidin for multiple sclerosis is currently recruiting in the UK. The study is sponsored by Swansea Universit…
-
CLINICAL_TRIALS research · 2026-03-05Clinical Trial Update: Deciphering Preserved Autonomic Function After Multiple Sclerosis [NA]
This Mayo Clinic-led clinical trial update describes a study evaluating preserved autonomic function after multiple sclerosis, including con…
-
CLINICAL_TRIALS research · 2026-03-05Clinical Trial Update: Clinical and Urodynamic Assessment of Bladder Sensation in Multiple Sclerosis [NA]
An ongoing clinical trial is assessing bladder sensation in people with multiple sclerosis using clinical and urodynamic measures. The condi…
-
EMA approval · 2026-03-03EMA Authorised: Zeposia (ozanimod hydrochloride) — Bristol-Myers Squibb Pharma EEIG
The EMA has authorised Zeposia (ozanimod hydrochloride) for relapsing-remitting multiple sclerosis and ulcerative colitis; the marketing aut…
-
CLINICAL_TRIALS trial_result · 2026-03-03Clinical Trial Update: Open Label Randomized Multicenter to Assess Efficacy & Tolerability of Ofatumumab 20mg vs. First Line DMT in RMS [Phase 3]
A completed Phase 3 open-label trial comparing ofatumumab 20 mg with a first-line disease-modifying therapy in relapsing multiple sclerosis …
-
CLINICAL_TRIALS research · 2026-03-03Clinical Trial Update: Exercise With and Without Cognitive Training [NA]
A VA Office of Research and Development–sponsored clinical trial is evaluating exercise with and without cognitive training for individuals …
-
CLINICAL_TRIALS research · 2026-03-03Clinical Trial Update: Effect of Music Therapy on Pain in People With Multiple Sclerosis [NA]
Clinical trial evaluating the effect of music therapy on pain in people with multiple sclerosis is currently recruiting.
-
EMA approval · 2026-03-02EMA Authorised: Fingolimod Accord (fingolimod hydrochloride) — Accord Healthcare S.L.U.
The EMA authorised Fingolimod Accord (fingolimod hydrochloride) from Accord Healthcare S.L.U. for relapsing-remitting multiple sclerosis.
-
CLINICAL_TRIALS trial_result · 2026-03-02Clinical Trial Update: ADAs to Alemtuzumab
This clinical trial update reports on anti-drug antibodies (immunogenicity) observed with alemtuzumab in people with multiple sclerosis.
-
CLINICAL_TRIALS research · 2026-03-02Clinical Trial Update: MRI-Based Lesion Differentiation in Older Patients With Multiple Sclerosis
This clinical trial update describes a study evaluating MRI-based differentiation of brain lesions in older adults with multiple sclerosis; …
-
CLINICAL_TRIALS trial_result · 2026-02-27Clinical Trial Update: A Study of Anti-CD19 Chimeric Antigen Receptor T-Cell ( CAR-T) Therapy in Subjects With Non-relapsing and Progressive Forms of Multiple Sclerosis [Phase 1]
A Phase 1 clinical trial sponsored by Stanford University is evaluating anti-CD19 CAR-T cell therapy for non-relapsing and progressive forms…
-
CLINICAL_TRIALS research · 2026-02-27Clinical Trial Update: Dalfampridine Combined With Physical Therapy for Mobility Impairment in Multiple Sclerosis [Phase 4]
This clinical trial update describes a Phase 4 study of dalfampridine combined with physical therapy for mobility impairment in multiple scl…
-
CLINICAL_TRIALS research · 2026-02-27Clinical Trial Update: Autologous Stem Cell Transplant for Neurologic Autoimmune Diseases [Phase 2]
Phase 2 clinical trial investigating autologous stem cell transplant for neurologic autoimmune diseases is currently active but not recruiti…
-
CLINICAL_TRIALS research · 2026-02-27Clinical Trial Update: The EXOPULSE Study - a Database for Routine Follow-up of Clinical Outcomes
The EXOPULSE Study is a clinical trial/database from Exoneural Network AB to collect routine clinical outcomes for several neurological cond…